Peter Jan Zimmermann

935 total citations
21 papers, 714 citations indexed

About

Peter Jan Zimmermann is a scholar working on Organic Chemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, Peter Jan Zimmermann has authored 21 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Peter Jan Zimmermann's work include Carbohydrate Chemistry and Synthesis (6 papers), Chemical Synthesis and Analysis (5 papers) and Hepatitis B Virus Studies (4 papers). Peter Jan Zimmermann is often cited by papers focused on Carbohydrate Chemistry and Synthesis (6 papers), Chemical Synthesis and Analysis (5 papers) and Hepatitis B Virus Studies (4 papers). Peter Jan Zimmermann collaborates with scholars based in Germany, France and Netherlands. Peter Jan Zimmermann's co-authors include Michael Nassal, Gunver S. Kienle, Helmut Kiene, Harald J. Hamre, Erik W. Baars, Wilm Buhr, Andreas Marc Palmer, Martin P. Feth, Volker Jäger and Andrea Dickhut and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Gut.

In The Last Decade

Peter Jan Zimmermann

21 papers receiving 668 citations

Peers

Peter Jan Zimmermann
Zahid Hussain India
K Jayashree India
Xiaoqin Lv China
Christine Röder Australia
Isabelle Lefèbvre France
Daniel Cohen United States
Jeffrey A. Burgess United States
Jennifer Chu United States
Chen-Lung Steve Lin Hong Kong
Ashish Dhawan India
Zahid Hussain India
Peter Jan Zimmermann
Citations per year, relative to Peter Jan Zimmermann Peter Jan Zimmermann (= 1×) peers Zahid Hussain

Countries citing papers authored by Peter Jan Zimmermann

Since Specialization
Citations

This map shows the geographic impact of Peter Jan Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Jan Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Jan Zimmermann more than expected).

Fields of papers citing papers by Peter Jan Zimmermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Jan Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Jan Zimmermann. The network helps show where Peter Jan Zimmermann may publish in the future.

Co-authorship network of co-authors of Peter Jan Zimmermann

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Jan Zimmermann. A scholar is included among the top collaborators of Peter Jan Zimmermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Jan Zimmermann. Peter Jan Zimmermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimmermann, Peter Jan, et al.. (2021). The Hepatitis B Virus Nucleocapsid—Dynamic Compartment for Infectious Virus Production and New Antiviral Target. Biomedicines. 9(11). 1577–1577. 33 indexed citations
2.
Lecoq, Lauriane, Shishan Wang, Peter Jan Zimmermann, et al.. (2021). A pocket-factor–triggered conformational switch in the hepatitis B virus capsid. Proceedings of the National Academy of Sciences. 118(17). 20 indexed citations
3.
Schuch, Anita, Elahe Salimi Alizei, Kathrin Heim, et al.. (2019). Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load. Gut. 68(5). 905–915. 118 indexed citations
4.
Zimmermann, Peter Jan, et al.. (2018). Hepatitis B virus core protein phosphorylation: Identification of the SRPK1 target sites and impact of their occupancy on RNA binding and capsid structure. PLoS Pathogens. 14(12). e1007488–e1007488. 64 indexed citations
5.
Zimmermann, Peter Jan, Andreas Weltin, G. Urban, & Jochen Kieninger. (2018). Active Potentiometry for Dissolved Oxygen Monitoring with Platinum Electrodes. Sensors. 18(8). 2404–2404. 21 indexed citations
6.
Kienle, Gunver S., et al.. (2013). Anthroposophic Medicine: An Integrative Medical System Originating in Europe. Global Advances in Health and Medicine. 2(6). 20–31. 136 indexed citations
7.
Palmer, Andreas Marc, Anja Schmid, Peter Jan Zimmermann, et al.. (2010). Tetrahydrochromenoimidazoles as Potassium-Competitive Acid Blockers (P-CABs): Structure−Activity Relationship of Their Antisecretory Properties and Their Affinity toward the hERG Channel. Journal of Medicinal Chemistry. 53(9). 3645–3674. 18 indexed citations
8.
Zimmermann, Peter Jan, et al.. (2008). Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis & Rheumatism. 58(9). 2743–2753. 81 indexed citations
9.
Palmer, Andreas Marc, et al.. (2008). Spiro(imidazo[1,2-a]pyrano[2,3-c]pyridine-9-indenes) as inhibitors of gastric acid secretion. Bioorganic & Medicinal Chemistry. 17(1). 368–384. 15 indexed citations
10.
Palmer, Andreas Marc, et al.. (2007). 5-Substituted 1H-pyrrolo[3,2-b]pyridines as inhibitors of gastric acid secretion. Bioorganic & Medicinal Chemistry. 16(3). 1511–1530. 24 indexed citations
11.
Zimmermann, Peter Jan, et al.. (2007). Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase. Bioorganic & Medicinal Chemistry Letters. 17(19). 5374–5378. 20 indexed citations
12.
Zimmermann, Peter Jan, et al.. (2007). Novel imidazo[1,2-a]pyrazine derivatives as potent reversible inhibitors of the gastric H+/K+-ATPase. Bioorganic & Medicinal Chemistry. 16(1). 536–541. 24 indexed citations
13.
Palmer, Andreas Marc, et al.. (2007). Preparation of tetrahydroimidazo[2,1-a]isoquinolines and their use as inhibitors of gastric acid secretion. Bioorganic & Medicinal Chemistry. 15(24). 7647–7660. 25 indexed citations
14.
Holmes, Michael A., et al.. (2006). Glucuronide conjugates of Soraprazan (BY359), a new potassium-competitive acid blocker (P-CAB) for the treatment of acid-related diseases. Tetrahedron Letters. 47(19). 3321–3323. 13 indexed citations
15.
Zimmermann, Peter Jan, et al.. (2005). Synthesis of L‐Furanomycin and Its Analogues via Furoisoxazolines. European Journal of Organic Chemistry. 2005(16). 3450–3460. 20 indexed citations
16.
Zimmermann, Peter Jan, et al.. (2000). A General Approach toL-(+)-Furanomycin and Some Stereoisomers and Analogues Using Furoisoxazoline Intermediates. Angewandte Chemie International Edition. 39(5). 910–912. 29 indexed citations
17.
Zimmermann, Peter Jan, et al.. (2000). Ein allgemeiner Zugang zuL-(+)-Furanomycin sowie einigen Stereoisomeren und Analoga unter Verwendung von Furoisoxazolinen. Angewandte Chemie. 112(5). 936–938. 6 indexed citations
18.
Groll, M. & Peter Jan Zimmermann. (1970). Das maximale Wärmetransportvermögen, optimal ausgelegter Wärmerohre. Chemie Ingenieur Technik. 42(15). 977–981. 3 indexed citations
19.
Groll, M. & Peter Jan Zimmermann. (1970). Instationäres Betriebsverhalten von Wärmerohren. Chemie Ingenieur Technik. 42(16). 1031–1034. 1 indexed citations
20.
Groll, M. & Peter Jan Zimmermann. (1969). Kenngrößen zum Beurteilen von Wärmeträgern für Wärmerohre. Chemie Ingenieur Technik. 41(24). 1294–1300. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zahid Hussain Breakdown of academic impact, for papers by K Jayashree Breakdown of academic impact, for papers by Xiaoqin Lv Breakdown of academic impact, for papers by Christine Röder Breakdown of academic impact, for papers by Isabelle Lefèbvre Breakdown of academic impact, for papers by Daniel Cohen Breakdown of academic impact, for papers by Jeffrey A. Burgess Breakdown of academic impact, for papers by Jennifer Chu Breakdown of academic impact, for papers by Chen-Lung Steve Lin Breakdown of academic impact, for papers by Ashish Dhawan
Rankless by CCL
2026